Evidence map›Paper›PMID 38756231›Full record

ArticleFrontiers in cellular and infection microbiology2024

Unraveling the adaptive strategies of

Olga V Pobeguts, Maria A Galaymina, Kirill V Sikamov, Diana R Urazaeva, Alexander S Avshalumov, Maria V Mikhailycheva, Vlad V Babenko, Igor P Smirnov, Alexey Yu Gorbachev

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Impact ofHealth science reports · 2026
    Review
  2. Article
  3. How to Unmask an Unknown: The Restriction-Modification SystemInternational journal of molecular sciences · 2026
    Article
  4. Genomic epidemiology and antimicrobial susceptibility of clinicalFrontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olga V PobegutsDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.
Maria A GalayminaDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.
Kirill V SikamovDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.
Diana R UrazaevaDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.
Alexander S AvshalumovDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.
Maria V MikhailychevaDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.
Vlad V BabenkoDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.
Igor P SmirnovDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.
Alexey Yu GorbachevDepartment of Molecular Biology and Genetics, Federal State Budgetary Institution Lopukhin Federal Research and Clinical Center of Physical-chemical Medicine Federal Medical Biological Agency, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: To investigate the adaptive properties of Results: We have shown that clinical isolates differ in phenotypic features from the laboratory strain, form biofilms more effectively and show resistance to ofloxacin. The comparative proteogenomic analysis revealed that, unlike the laboratory strain, the clinical isolates possess several features related to stress survival: they switch carbon metabolism, activating the energetically least advantageous pathway of nucleoside utilization, which allows slowing down cellular processes and transitioning to a starvation state; they reconfigure the repertoire of membrane proteins; they have integrative conjugative elements in their genomes, which are key mediators of horizontal gene transfer. The upregulation of the methylating subunit of the restriction-modification (RM) system type I and the additional components of RM systems found in clinical isolates suggest that DNA methylation may play a role in regulating the adaptation mechanisms of Discussion: We believe that the key mechanism of adaptation of

Indexed as

Adaptation, PhysiologicalMycoplasma hominisMycoplasma InfectionsProteogenomicsAnti-Bacterial AgentsBacterial ProteinsBiofilmsDrug Resistance, BacterialGenome, BacterialHumansPhenotypeAnti-Bacterial AgentsBacterial Proteinsadaptation to hostclinical isolatesmini coloniesMycoplasma hominisphenotype switchproteogenomic analysis

Identifiers

PMID38756231
PMCPMC11096450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.